View Item 

Show simple item record

Impact of Medicare Part D on out‐of‐pocket drug costs and medical use for patients with cancer
dc.contributor.authorKircher, Sheetal M.en_US
dc.contributor.authorJohansen, Michael E.en_US
dc.contributor.authorNimeiri, Halla S.en_US
dc.contributor.authorRichardson, Caroline R.en_US
dc.contributor.authorDavis, Matthew M.en_US
dc.date.accessioned2014-11-04T16:35:53Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-11-04T16:35:53Z
dc.date.issued2014-11-01en_US
dc.identifier.citationKircher, Sheetal M.; Johansen, Michael E.; Nimeiri, Halla S.; Richardson, Caroline R.; Davis, Matthew M. (2014). "Impact of Medicare Part D on out‐of‐pocket drug costs and medical use for patients with cancer." Cancer 120(21): 3378-3384.en_US
dc.identifier.issn0008-543Xen_US
dc.identifier.issn1097-0142en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/109348
dc.publisherAgency for Healthcare Research and Qualityen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherMedicare Part Den_US
dc.subject.otherPrescription Drugs/Economicsen_US
dc.subject.otherDrug Costsen_US
dc.subject.otherNeoplasmsen_US
dc.subject.otherModels Economicen_US
dc.titleImpact of Medicare Part D on out‐of‐pocket drug costs and medical use for patients with canceren_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/109348/1/cncr28898.pdf
dc.identifier.doi10.1002/cncr.28898en_US
dc.identifier.sourceCanceren_US
dc.identifier.citedreferenceBond AM, White C. Massachusetts coverage expansion associated with reduction in primary care utilization among Medicare beneficiaries. Health Serv Res. 2013; 48 ( 6 pt 1 ): 1826 ‐ 1839.en_US
dc.identifier.citedreferenceThe Henry J. Kaiser Family Foundation. USA Today/Kaiser Family Foundation/Harvard School of Public Health National Survey of Households Affected by Cancer. kff.org/kaiserpolls/pomr112006pkg.cfm. Accessed September 13, 2012.en_US
dc.identifier.citedreferenceZafar Y, Goetzinger M, Fowler R, et al. Impact of out‐of‐pocket expenses on cancer care [abstract]. J Clin Oncol. 2011; May 20 supplement. Abstract 6006.en_US
dc.identifier.citedreferenceStump TK, Eghan N, Egleston BL, et al. Cost concerns of patients with cancer. J Oncol Pract. 2013; 9: 251 ‐ 257.en_US
dc.identifier.citedreferenceRamsey S, Blough D, Kirchhoff A, et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013; 32: 1143 ‐ 1152.en_US
dc.identifier.citedreferenceArozullah AM, Calhoun EA, Wolf M, et al. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004; 2: 271 ‐ 278.en_US
dc.identifier.citedreferenceLanga KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL, Hayman JA. Out‐of‐pocket health‐care expenditures among older Americans with cancer. Value Health. 2004; 7: 186 ‐ 194.en_US
dc.identifier.citedreferenceBernard DS, Farr SL, Fang Z. National estimates of out‐of‐pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011; 29: 2821 ‐ 2826.en_US
dc.identifier.citedreferenceZafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out‐of‐pocket expenses and the insured cancer patient's experience. Oncologist. 2013; 18: 381 ‐ 390.en_US
dc.identifier.citedreferenceMedical Expenditure Panel Survey. Data Files for Years 1996‐2010. meps.ahrq.gov/mepsweb/data_stats/download_data_files.jsp. Accessed July 26, 2013.en_US
dc.identifier.citedreferenceKetcham JD, Simon KI. Medicare Part D's effects on elderly patients' drug costs and utilization. Am J Manag Care. 2008; 14 ( suppl 11 ): SP14 ‐ SP22.en_US
dc.identifier.citedreferenceZhang JX, Yin W, Sun SX, Alexander GC. The impact of the Medicare Part D prescription benefit on generic drug use. J Gen Intern Med. 2008; 23: 1673 ‐ 1678.en_US
dc.identifier.citedreferenceGrootendorst PV, O'Brien BJ, Anderson GM. On becoming 65 in Ontario. Effects of drug plan eligibility on use of prescription medicines. Med Care. 1997; 35: 386 ‐ 398.en_US
dc.identifier.citedreferenceCerner Multum. Lexicon Plus. multum.com/lexicon.html. Accessed January 21, 2014.en_US
dc.identifier.citedreferenceAbadie A. Semiparametric differences‐in‐differences estimators. Rev Econ Stud. 2005; 72: 1 ‐ 19.en_US
dc.identifier.citedreferenceBian J, Bennett CL, Fisher DA, Ribeiro M, Lipscomb J. Unintended consequences of health information technology: evidence from veterans affairs colorectal cancer oncology watch intervention. J Clin Oncol. 2012; 30: 3947 ‐ 3952.en_US
dc.identifier.citedreferenceMcConnell KJ, Gast SH, Ridgely MS, et al. Behavioral health insurance parity: does Oregon'ss experience presage the national experience with the Mental Health Parity and Addiction Equity Act? Am J Psychiatry. 2012; 169: 31 ‐ 38.en_US
dc.identifier.citedreferenceSommers BD, Baicker K, Epstein AM. Mortality and access to care among adults after state Medicaid expansions. N Engl J Med. 2012; 367: 1025 ‐ 1034.en_US
dc.identifier.citedreferenceManning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001; 20: 461 ‐ 494.en_US
dc.identifier.citedreferenceManning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005; 24: 465 ‐ 488.en_US
dc.identifier.citedreferenceOlsen MK, Schafer JL. A 2‐part random‐effects model for semicontinuous longitudinal data. J Am Stat Assoc. 2001; 96: 730 ‐ 745.en_US
dc.identifier.citedreferenceYu WW. Confidence Intervals for Skewed Healthcare Expenditure Data From the Medical Expenditure Panel Survey (MEPS). Rockville, MD: Agency for Healthcare Research and Quality; 2004.en_US
dc.identifier.citedreferenceYau KK, Wang K, Lee AH. Zero‐inflated negative binomial mixed regression modeling of over‐dispersed count data with extra zeros. Biom J. 2003; 45: 437 ‐ 452.en_US
dc.identifier.citedreferenceBriesacher BA, Stuart B, Ren X, Doshi JA, Wrobel MV. Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending. Health Serv Res. 2005; 40 ( 5 pt 1 ): 1279 ‐ 1296.en_US
dc.identifier.citedreferenceKhan N, Kaestner R, Lin SJ. Effect of prescription drug coverage on health of the elderly. Health Serv Res. 2008; 43 ( 5 pt 1 ): 1576 ‐ 1597.en_US
dc.identifier.citedreferenceDoherty RB. Assessing the new Medicare prescription drug law. Ann Intern Med. 2004; 141: 391 ‐ 395.en_US
dc.identifier.citedreferenceLiu FX, Alexander GC, Crawford SY, Pickard AS, Hedeker D, Walton SM. The impact of Medicare Part D on out‐of‐pocket costs for prescription drugs, medication utilization, health resource utilization, and preference‐based health utility. Health Serv Res. 2011; 46: 1104 ‐ 1123.en_US
dc.identifier.citedreferenceLichtenberg FR, Sun SX. The impact of Medicare Part D on prescription drug use by the elderly. Health Aff (Millwood). 2007; 26: 1735 ‐ 1744.en_US
dc.identifier.citedreferenceSimoni‐Wastila L, Zuckerman IH, Shaffer T, Blanchette CM, Stuart B. Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage. Health Serv Res. 2008; 43: 496 ‐ 514.en_US
dc.identifier.citedreferenceYin W, Basu A, Zhang JX, Rabbani A, Meltzer DO, Alexander GC. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med. 2008; 148: 169 ‐ 177.en_US
dc.identifier.citedreferenceEheman C, Henley SJ, Ballard‐Barbash R, et al. Annual Report to the Nation on the status of cancer, 1975‐2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer. 2012; 118: 2338 ‐ 2366.en_US
dc.identifier.citedreferenceMariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010‐2020. J Natl Cancer Inst. 2011; 103: 117 ‐ 128.en_US
dc.identifier.citedreferenceCancer Trends Progress Report‐ 2009/2010 Update, National Cancer Institute. http://progressreport.cancer.gov. Accessed April 1, 2014.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr28898.pdf
Size:
105.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.